The miss breaks 4 quarters of beats, eroding the momentum narrative. With -7.95% avg T+20 P&L on prior RMD calls and calibration showing negative net alpha, this filing reinforces the bearish drift. Watch the William Blair conference (June 2) for any FY guidance color — a lower FY guide would compound the miss.
Price Chart
Executive Summary
Resmed reports fiscal Q3 2026 EPS of $2.86, a 1.4% miss vs consensus of $2.90. The miss breaks a streak of four consecutive beats, and historical calibration on RMD shows poor follow-through on prior long calls. This is a modest negative relative to expectations for a med-tech bellwether, though absolute profit levels remain solid.
Key Financial Metrics
Key Facts
- EPS of $2.86 missed consensus estimate of $2.90 by $0.04 (1.4% miss)
- Street-convention EPS reversed a multi-quarter beat streak where prior 4 quarters beat consensus by 2.4-4.5%
- Revenue of $1.46B matched consensus (in-line, per provided context; no explicit beat/miss figure stated)
- Historical calibration data show only 17% win rate on prior RMD calls at T+20, with avg P&L of -7.95%
- No guidance change was provided; filing is an earnings miss without a mitigating guidance raise
Financial Impact
Miss of $0.04/share vs consensus; revenue in-line at $1.46B
Risk Factors
- EPS miss breaks positive surprise momentum, likely to pressure near-term valuation multiple
- No explicit guidance provided in this release; ambiguity around whether this was a one-quarter noise or a trend shift
- Historical performance shows RMD has not rewarded bullish or long calls over 20-day horizon
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3297946 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | Insider Cluster | $219.58 $228.42 | ▲ +4.03% | ▲ +4.52% | $218.89 (−0.31%) |
Aug 11, 2026 7w ago | Insider Cluster | $224.84 $219.98 | ▼ −2.16% | ▼ −1.76% | $218.89 (−2.65%) |
Jul 7, 2026 12w ago | Press Release | $205.84 $193.01 | ▼ −6.23% | ▼ −7.10% | $218.89 (+6.34%) |
Jun 1, 2026 17w ago | Press Release | $182.75 $196.94 | ▲ +7.77% | ▲ +10.73% | $218.89 (+19.78%) |
May 19, 2026 19w ago | Press Release | $209.14 $203.22 | ▲ +2.83% | ▲ +4.63% | $218.89 (−4.66%) |
Apr 1, 2026 26w ago | Press Release | $224.09 $228.07 | ▲ +1.78% | ▼ −1.84% | $218.89 (−2.32%) |
Apr 1, 2026 26w ago | Insider Cluster | $222.19 $228.02 | ▲ +2.62% | ▼ −1.14% | $218.89 (−1.48%) |
Apr 1, 2026 26w ago | Insider Cluster | $222.19 $228.02 | ▼ −2.62% | ▲ +1.14% | $218.89 (+1.48%) |
Mar 2, 2026 30w ago | Insider Cluster | $256.94 $252.06 | ▼ −1.90% | ▼ −0.69% | $218.89 (−14.81%) |
Mar 2, 2026 30w ago | Insider Cluster | $256.94 $252.06 | ▼ −1.90% | ▼ −0.69% | $218.89 (−14.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access